Hemostatic factors as triggers of cardiovascular events.

scientific article published on May 1996

Hemostatic factors as triggers of cardiovascular events. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0733-8651(05)70277-0
P698PubMed publication ID8724556

P2093author name stringG H Tofler
G B Rosito
P2860cites workFinal report on the aspirin component of the ongoing Physicians' Health StudyQ29619461
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and deathQ33611676
Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study InvestigatorsQ34305035
Epidemiological characteristics of platelet aggregability.Q34489552
Plasminogen activator inhibitor in the blood of patients with coronary artery diseaseQ34490676
Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observationsQ36492452
Prospective evidence of a circadian rhythm for out-of-hospital cardiac arrestsQ39239371
Psychological stress and fatal heart attack: the Athens (1981) earthquake natural experimentQ39340265
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study GroupQ39522420
Circadian variation of blood-pressureQ39539239
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo anginaQ39817564
Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literatureQ40904739
The genetic contribution to the risk of thrombosis and cardiovascular diseaseQ41046486
Endogenous tissue-type plasminogen activator and risk of myocardial infarctionQ41079493
Post-exercise platelet activation--aggregation and release in relation to dynamic exerciseQ41193354
Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physiciansQ41205463
Platelet hyperreactivity and prognosis in survivors of myocardial infarctionQ41229453
Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?Q41263009
Circadian variation in the frequency of onset of acute myocardial infarctionQ41781518
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study GroupQ43586287
Effect of chronic smoking on fibrinolysis.Q43599628
Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjectsQ43602119
Determinants of plasma fibrinogen: relation to body weight, waist-to-hip ratio, smoking, alcohol, age, and sex. Results from the second MONICA Augsburg survey 1989-1990Q43613193
Influence of platelet size on outcome after myocardial infarctionQ43705998
Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study GroupQ43946010
Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat compositionQ44134035
Morning increase in platelet aggregability. Association with assumption of the upright postureQ44375517
Platelet activation and secretion associated with emotional stressQ44593115
Impaired fibrinolysis in coronary artery diseaseQ46100210
An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosisQ47977843
FIBRINOLYTIC ACTIVITY AND ANXIETY AND ITS RELATION TO CORONARY ARTERY DISEASE.Q51350727
Blood fibrinolytic activity in man. Diurnal variation and the response to varying intensities of exercise.Q51683878
Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension.Q52034758
Cardiovascular disease risk profiles.Q52461317
Fibrinogen and risk of cardiovascular disease. The Framingham Study.Q52588834
Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia.Q53707508
Effect of exercise on platelet count, adhesion, and aggregation.Q53795895
Circadian variation in the efficacy of tissue-type plasminogen activator.Q54013104
Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity.Q54286663
Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.Q54314674
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.Q55060856
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular diseaseQ58475992
Whole blood impedance platelet aggregometry and ischemic heart disease. The Caerphilly Collaborative Heart Disease StudyQ60687362
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulationQ60924885
Haemostatic variables associated with diabetes and its complicationsQ66971398
A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarctionQ67295801
Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitusQ67700735
Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectorisQ67989768
Circadian variation in platelet function in healthy volunteersQ68053894
Dietary regulation of fibrinolytic factorsQ68433697
Twenty-four hour pattern of the episodic secretion of cortisol in normal subjectsQ68627349
Moderate alcohol consumption and platelet aggregation in healthy middle-aged menQ68635798
Elevation of C-reactive protein in "active" coronary artery diseaseQ68696120
Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham StudyQ68979773
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitusQ69018082
Diurnal changes in coronary blood flow in conscious dogsQ69122941
Ethanol ingestion inhibits human whole blood platelet impedance aggregationQ69258987
Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery diseaseQ69485574
Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasmaQ69557282
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart StudyQ69886150
Effects of moderate alcohol consumption on platelet aggregation, fibrinolysis, and blood lipidsQ69900158
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarctionQ69973450
Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusionQ70238189
The significance of platelet-vessel wall prostaglandin equilibrium during exercise-induced stressQ70261111
Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrationsQ70322551
Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and strokeQ70401843
Haemostatic changes following surgeryQ70460775
Effect of strenuous exercise on platelet activation state and reactivityQ70489175
Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic deathQ71306624
Thromboxane production and platelet aggregation in diabetic subjects with clinical complicationsQ71417827
Fibrinogen as a risk factor for stroke and myocardial infarctionQ71438059
Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusionsQ71482308
The effect of exercise on haematocrit, plasma volume and viscosity in diabetes mellitusQ71768168
Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring StudyQ72642216
P433issue2
P304page(s)239-250
P577publication date1996-05-01
P1433published inCardiology clinicsQ2600141
P1476titleHemostatic factors as triggers of cardiovascular events
P478volume14

Reverse relations

cites work (P2860)
Q50854564Circadian variation in the onset of acute critical limb ischemia.
Q79768905Heart rate variability, hemostatic and acute inflammatory blood parameters in healthy adults after short-term exposure to welding fume
Q77853669Increased winter mortality from acute myocardial infarction and stroke: the effect of age

Search more.